I think the problem here is that it takes till H1 '24 to get the results of the toxic study and then "...for the FDA toallow dosing of ATL1102 for a term longer than six months in the US..." no data readout included. so lets be honest, before '25 there will be no final product which will generate sales. Which is approximately 2 - 2 1/2 years away from now. Why should any big player jump in on such news if there are no sales to be expected... or anyone else. Don't get me wrong, i am holding ANP shares for a while now but i knew that there will be no profit out of this before 25. The expectations are high but the only thing i am taking out of such news is that we have to wait and wait and wait and wait....
I think the problem here is that it takes till H1 '24 to get the...
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.0¢ |
Change
0.003(3.90%) |
Mkt cap ! $72.12M | |||
| Open | High | Low | Value | Volume |
| 7.9¢ | 8.3¢ | 7.9¢ | $147.1K | 1.826M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300000 | 7.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.3¢ | 106165 | 2 |
View Market Depth
| Last trade - 16.10pm 08/05/2024 (20 minute delay) ? |
|
|||||
|
Last
8.0¢ |
Change
0.003 ( 3.90 %) |
||||
| Open | High | Low | Volume | ||
| 7.9¢ | 8.3¢ | 7.9¢ | 108394 | ||
| Last updated 15.59pm 08/05/2024 ? | |||||
| PER (ASX) Chart |